Your browser doesn't support javascript.
loading
microRNA Expression and Its Association With Disability and Brain Atrophy in Multiple Sclerosis Patients Treated With Glatiramer Acetate.
Dominguez-Mozo, María I; Casanova, Ignacio; De Torres, Laura; Aladro-Benito, Yolanda; Perez-Perez, Silvia; Garcia-Martínez, Angel; Gomez, Patricia; Abellan, Sara; De Antonio, Esther; Lopez-De-Silanes, Carlos; Alvarez-Lafuente, Roberto.
Afiliação
  • Dominguez-Mozo MI; Research Group in Environmental Factors of Neurodegenerative Diseases, Health Research Institute Hospital Clínico San Carlos (IdISSC), Madrid, Spain.
  • Casanova I; Department of Neurology, Hospital Universitario de Torrejón, Madrid, Spain.
  • De Torres L; School of Medicine, Universidad Francisco de Vitoria, Madrid, Spain.
  • Aladro-Benito Y; Department of Neurology, Hospital Universitario de Torrejón, Madrid, Spain.
  • Perez-Perez S; Department of Neurology, Hospital Universitario de Getafe, Madrid, Spain.
  • Garcia-Martínez A; Research Group in Environmental Factors of Neurodegenerative Diseases, Health Research Institute Hospital Clínico San Carlos (IdISSC), Madrid, Spain.
  • Gomez P; Research Group in Environmental Factors of Neurodegenerative Diseases, Health Research Institute Hospital Clínico San Carlos (IdISSC), Madrid, Spain.
  • Abellan S; Department of Neurology, Hospital Universitario de Torrejón, Madrid, Spain.
  • De Antonio E; School of Medicine, Universidad Francisco de Vitoria, Madrid, Spain.
  • Lopez-De-Silanes C; Department of Neurology, Hospital Universitario de Torrejón, Madrid, Spain.
  • Alvarez-Lafuente R; Department of Radiology, Hospital Universitario de Torrejón, Madrid, Spain.
Front Immunol ; 13: 904683, 2022.
Article em En | MEDLINE | ID: mdl-35774792

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Doenças do Sistema Nervoso Central / Doenças Neurodegenerativas / MicroRNAs / Esclerose Múltipla Tipo de estudo: Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Front Immunol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Espanha

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Doenças do Sistema Nervoso Central / Doenças Neurodegenerativas / MicroRNAs / Esclerose Múltipla Tipo de estudo: Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Front Immunol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Espanha